Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Intracranial, Neoplasms, Nerve Tissue, Pituitary Neoplasms, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, grade II meningioma, grade III meningioma, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, meningioma, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroma, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, pituitary gland adenoma, pituitary gland disorder, primitive neuroectodermal tumor, schwannoma, supratentorial cancer, tumor of meninges, vascular cancer	Recruiting	Not applicable	2026-02-17		NCT04278118

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emory University	393
National Cancer Institute (NCI)	3015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory University Hospital/Winship Cancer Institute	Atlanta	United States	299